Abstract:The MtrCDE efflux pump of Neisseria gonorrhoeae exports a wide range of antimicrobial compounds that the gonococcus encounters at mucosal surfaces during colonization and infection and is a known gonococcal virulence factor. Here, we evaluate the role of this efflux pump system in strain FA1090 during in vivo human male urethral infection with N. gonorrhoeae using a controlled human infection model. With the strategy of competitive infections initiated with mixtures of wild-type FA1090 and an isogenic mutant FA1090 strain that does not contain a functional MtrCDE pump, we found that the presence of the efflux pump is not required for an infection to be established in the human male urethra. This finding contrasts with previous studies of in vivo infection in the lower genital tract of female mice, which demonstrated that mutant gonococci of a different strain (FA19) lacking a functional MtrCDE pump had a significantly reduced fitness compared to their wild-type parental FA19 strain. To determine if these conflicting results are due to strain or human vs . mouse differences, we conducted a series of systematic competitive infections in female mice with the same FA1090 strains as in humans, and with FA19 strains, including mutants that do not assemble a functional MtrCDE efflux pump. Our results indicate the fitness advantage provided by the MtrCDE efflux pump during infection of mice is strain dependent. Owing to the equal fitness of the two FA1090 strains in men, our experiments also demonstrated the presence of a colonization bottleneck of N. gonorrhoeae in the human male urethra, which may open a new area of inquiry into N. gonorrhoeae infection dynamics and control. TRIAL REGISTRATION . Clinicaltrials.gov NCT03840811. The work herein uses a unique controlled human infection model to examine the importance of a known Neisseria gonorrhoeae virulence factor, namely the multiple transferrable resistance (MtrCDE) efflux pump, to in vivo gonorrhea in human male urethra. The MtrCDE efflux pump is an important contributor to antimicrobial resistance because it enhances the ability of N. gonorrhoeae to withstand the action of multiple classes of antibiotics by facilitating the export of these compounds out of the bacterial cell. Antimicrobial resistant Neisseria gonorrhoeae is recognized by the US Centers for Disease Control as an urgent threat emerging in the antimicrobial resistance space and as a priority pathogen for antimicrobial resistance monitoring by the World Health Organization. Prior to the work described in this manuscript, studies performed in vitro and in vivo using the mouse model of infection had suggested that MtrCDE confers N. gonorrhoeae a within-host competitive advantage, even in the absence of antibiotic treatment, presumed to be related to the pump's ability to act on endogenous host derived antimicrobial factors. Our study demonstrates that the pump is not required for human infection and that it does not confer a competitive advantage in the human male urethral infection, at least in the context of the N. gonorrhoeae strain approved for use in experimental infections in humans. In addition, our study also revealed a previously unrecognized within-host bottleneck to the establishment of a productive urethral infection. Host bottlenecks have been described for other human pathogens, but never before for a bacterial sexually-transmitted pathogen. This observation opens an entirely new avenue of research inquiry that ultimately will help us better understand the pathogenesis of N. gonorrhoeae colonization and identify potential points for development of novel preventative measures.

Hormonal steroids induce multidrug resistance and stress response genes in Neisseria gonorrhoeae by binding to MtrR

Neisseria gonorrhoeae ST-1901 in Rio de Janeiro from 2006 to 2022: Phylogeny and antimicrobial resistance evolution of a well-succeeded pathogen

Antibiotic Resistance and Treatment Options for Multidrug-Resistant Gonorrhea

Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).

Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid Against Multidrug-Resistant Neisseria Gonorrhoeae

Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model

Impact of the Gonococcal FC428 Pena Allele 60.001 on Ceftriaxone Resistance and Biological Fitness.

Th1-polarized MtrE-based Gonococcal Vaccines Display Prophylactic and Therapeutic Efficacy.

Sex Steroids Induce Membrane Stress Responses and Virulence Properties in Pseudomonas aeruginosa

Experimental genital tract infection demonstrates Neisseria gonorrhoeae MtrCDE efflux pump is not required for in vivo human infection and identifies gonococcal colonization bottleneck

Modulation of Steroidogenic Gene Expression and Hormone Production of H295R Cells by Pharmaceuticals and Other Environmentally Active Compounds.

Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae

Effect of Progesterone on Gonococci-Induced Apoptosis and Respiratory Burst of Human Polymorphonuclear Leukocytes in Vitro

Influence of selected non-antibiotic pharmaceuticals on antibiotic resistance gene transfer in Escherichia coli

Transcriptional activation of ompA in Neisseria gonorrhoeae mediated by the XRE family member protein NceR

Investigating the cause of increased tetracycline-resistant Neisseria gonorrhoeae in England, 2016–20

Progesterone promotes CXCl2-dependent vaginal neutrophil killing by activating cervical resident macrophage-neutrophil crosstalk

Sex Hormones Alter Iron Acquisition and Virulence Factors

Genotypic and Phenotypic Characterization of Antimicrobial Resistance in Neisseria gonorrhoeae: a Cross-Sectional Study of Isolates Recovered from Routine Urine Cultures in a High-Incidence Setting

Estrogen Suppresses Cytokines Release in cc4821 Neisseria meningitidis Infection via TLR4 and ERβ-p38-MAPK Pathway

Structural Basis of Peptide-Based Antimicrobial Inhibition of a Resistance-Nodulation-Cell Division Multidrug Efflux Pump